Large increase in cardiac output in a patient with ARDS and acute right heart failure during inhalation of nitric oxide

Background Inhaled nitric oxide (NO), a selective pulmonary vasodilator, reduces pulmonary artery pressure in patients with acute respiratory distress syndrome (ARDS). In spite of the reduction of right ventricular afterload, the effect of NO on cardiac output remains unclear. Methods:A patient with...

Full description

Saved in:
Bibliographic Details
Published inActa anaesthesiologica Scandinavica Vol. 41; no. 5; pp. 643 - 646
Main Authors BENZING, A., MOLS, G., BEYER, U., GEIGER, K.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.05.1997
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Inhaled nitric oxide (NO), a selective pulmonary vasodilator, reduces pulmonary artery pressure in patients with acute respiratory distress syndrome (ARDS). In spite of the reduction of right ventricular afterload, the effect of NO on cardiac output remains unclear. Methods:A patient with ARDS and echocardiographically determined severe acute right heart failure was treated with increasing concentrations of inhaled nitric oxide (NO). Haemo‐dynamic and gas exchange variables were determined for each concentration of NO. NO treatment was continued for 3 days. Results:During initial right heart failure, administration of NO: resulted in a large increase (32%) in cardiac output in a dose‐dependent manner. When right ventricular function had improved, inhalation of NO did not increase cardiac output. Conclusion: Our observations suggest that inhalation of NO is likely to increase cardiac output in ARE when severe acute right heart failure is present.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0001-5172
1399-6576
DOI:10.1111/j.1399-6576.1997.tb04758.x